Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Direct-to-consumer advertising can be a controversial topic in the pharma industry. While the US isn’t the only other country ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, over-the-counter (OTC) and prescription options are available.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The state has not disclosed how much it paid to acquire pentobarbital, the drug used in the recent execution of convicted ...